Performance of Molecular Inversion Probe DR23K and Paragon MAD4HatTeR Amplicon Sequencing Panels for Detection of Plasmodium falciparum Mutations Associated with Antimalarial Drug Resistance.

Thomas Katairo, Victor Asua, Bienvenu Nsengimaana, Stephen Tukwasibwe, Francis D Semakuba, Innocent Wiringilimaana, Shreeya Garg, Shahiid Kiyaga, Monica Mbabazi, Kisakye D Kabbale, Alisen Ayitewala, Samuel L Nsobya, Moses R Kamya, Issac Ssewanyana, Jeffrey A Bailey, Andrés Aranda-Díaz, Philip J Rosenthal, Bryan Greenhouse, Jessica Briggs, Melissa D Conrad
Author Information
  1. Thomas Katairo: Infectious Diseases Research Collaboration.
  2. Victor Asua: Infectious Diseases Research Collaboration.
  3. Bienvenu Nsengimaana: Infectious Diseases Research Collaboration.
  4. Stephen Tukwasibwe: Infectious Diseases Research Collaboration.
  5. Francis D Semakuba: Infectious Diseases Research Collaboration.
  6. Innocent Wiringilimaana: Infectious Diseases Research Collaboration.
  7. Shreeya Garg: University of California, San Francisco.
  8. Shahiid Kiyaga: Infectious Diseases Research Collaboration.
  9. Monica Mbabazi: Infectious Diseases Research Collaboration.
  10. Kisakye D Kabbale: Infectious Diseases Research Collaboration.
  11. Alisen Ayitewala: Uganda National Health Laboratory Services (UNHLS)/Central Public Health Laboratories (CPHL).
  12. Samuel L Nsobya: Infectious Diseases Research Collaboration.
  13. Moses R Kamya: Infectious Diseases Research Collaboration.
  14. Issac Ssewanyana: Infectious Diseases Research Collaboration.
  15. Jeffrey A Bailey: Brown University.
  16. Andrés Aranda-Díaz: University of California, San Francisco.
  17. Philip J Rosenthal: University of California, San Francisco.
  18. Bryan Greenhouse: University of California, San Francisco.
  19. Jessica Briggs: University of California, San Francisco.
  20. Melissa D Conrad: University of California, San Francisco.

Abstract

Background: Molecular surveillance of drug-resistant is crucial for malaria control in endemic regions. Two targeted-resequencing tools, the Molecular Inversion Probe (MIP) drug resistance panel DR23K and the Multiplexed Amplicons for Drugs, Diagnostics, Diversity, and Differentiation using High-Throughput Targeted Resequencing (MADHatTeR) panel, are widely used to detect resistance genotypes. However, comparisons of their performance for genotyping drug resistance polymorphisms in malaria parasites and their comparative utility for other use cases is lacking.
Methods: To compare the performance of DR23K and MADHatTeR in terms of sequencing depth, sensitivity to minor alleles, and precision, each platform was used to evaluate SNP alleles and microhaplotypes in double- and triple-strain mixtures of well-characterized laboratory parasites at densities of 10, 100, 1,000, and 10,000 parasites/μL. In addition, 67 Ugandan field samples collected in 2022 were genotyped using each platform to assess performance and concordance.
Results: Across the four parasite densities, MADHatTeR exhibited superior sequencing depth (mean reads per locus: 144, 992, 1,153, and 1,300) compared to DR23K (mean unique molecular identifiers [UMIs] per locus: 1, 4, 49, and 364). For SNP detection, MADHatTeR achieved 100% sensitivity at 2% within-sample allele frequency (WSAF) at 1,000 and 10,000 parasites/μL, whereas DR23K achieved 100% sensitivity at 40% and 5% WSAF at these densities, respectively. Microhaplotype sensitivity was lower for both assays; MAD4HatTeR reached 69% sensitivity at 10 parasites/μL when WSAF was ≥ 10%, increasing to 100% sensitivity at 2% WSAF and 100 parasites/μL. DR23K had < 50% sensitivity at 10 and 100 parasites/μL. In field samples, which commonly contain polyclonal infections, high concordance was observed between the two methods for all SNPs (94%, 1,848/1,969) and polymorphic SNPs (88%, 898/1,019). All discrepancies were attributed to varied detection of minority alleles in mixed genotype infections.
Conclusions: MADHatTeR demonstrated higher sensitivity than DR23K, particularly at low parasite densities. Both assays showed strong concordance for genotyping key resistance mutations in field samples, supporting their reliability. These findings suggest MADHatTeR as the preferred assay for low-density parasite studies and microhaplotype analysis, while DR23K may be appropriate for specific applications with high-parasite density samples, where detection of minority alleles is not prioritized, or when more comprehensive genome coverage is required.

Keywords

References

  1. PLoS Med. 2015 Mar 03;12(3):e1001788 [PMID: 25734259]
  2. Genetics. 2019 Aug;212(4):1337-1351 [PMID: 31209105]
  3. Antimicrob Agents Chemother. 2020 Mar 24;64(4): [PMID: 31932374]
  4. PLoS Pathog. 2024 Sep 23;20(9):e1012194 [PMID: 39312594]
  5. PLoS One. 2018 Sep 20;13(9):e0204347 [PMID: 30235327]
  6. Bio Protoc. 2023 Mar 05;13(5):e4621 [PMID: 36908639]
  7. J Infect Dis. 2022 Apr 1;225(7):1227-1237 [PMID: 32840625]
  8. Trends Parasitol. 2024 Feb;40(2):147-163 [PMID: 38129280]
  9. Nat Med. 2023 Dec;29(12):3203-3211 [PMID: 37884028]
  10. Nat Commun. 2024 Feb 15;15(1):1413 [PMID: 38360754]
  11. Elife. 2021 Aug 10;10: [PMID: 34372970]
  12. J Infect Dis. 2018 Aug 14;218(6):946-955 [PMID: 29718283]
  13. PLOS Glob Public Health. 2024 Feb 1;4(2):e0002743 [PMID: 38300956]
  14. Nat Commun. 2022 Oct 26;13(1):6353 [PMID: 36289202]
  15. Antimicrob Agents Chemother. 2015;59(6):3018-30 [PMID: 25753626]
  16. Mol Ecol Resour. 2022 Aug;22(6):2285-2303 [PMID: 35437908]
  17. N Engl J Med. 2023 Aug 24;389(8):722-732 [PMID: 37611122]
  18. Sci Rep. 2025 Mar 28;15(1):10737 [PMID: 40155691]

Grants

  1. K24 AI144048/NIAID NIH HHS
  2. R01 AI075045/NIAID NIH HHS
  3. R01 AI173557/NIAID NIH HHS
  4. U19 AI089674/NIAID NIH HHS

Word Cloud

Created with Highcharts 10.0.0DR23KsensitivityMADHatTeR1resistance10parasites/μLMolecularallelesdensities000samplesWSAFInversiondrugperformance100fieldconcordanceparasitedetection100%MAD4HatTeRSNPsmalariaProbepanelusingusedgenotypingparasitessequencingdepthplatformSNPmeanperlocus:achieved2%assaysinfectionsminorityAntimalarialBackground:surveillancedrug-resistantcrucialcontrolendemicregionsTwotargeted-resequencingtoolsMIPMultiplexedAmpliconsDrugsDiagnosticsDiversityDifferentiationHigh-ThroughputTargetedResequencingwidelydetectgenotypesHowevercomparisonspolymorphismscomparativeutilityusecaseslackingMethods:comparetermsminorprecisionevaluatemicrohaplotypesdouble-triple-strainmixtureswell-characterizedlaboratoryaddition67Ugandancollected2022genotypedassessResults:Acrossfourexhibitedsuperiorreads144992153300compareduniquemolecularidentifiers[UMIs]449364within-sampleallelefrequencywhereas40%5%respectivelyMicrohaplotypelowerreached69%10%increasing<50%commonlycontainpolyclonalhighobservedtwomethods94%848/1969polymorphic88%898/1019discrepanciesattributedvariedmixedgenotypeConclusions:demonstratedhigherparticularlylowshowedstrongkeymutationssupportingreliabilityfindingssuggestpreferredassaylow-densitystudiesmicrohaplotypeanalysismayappropriatespecificapplicationshigh-parasitedensityprioritizedcomprehensivegenomecoveragerequiredPerformanceParagonAmpliconSequencingPanelsDetectionPlasmodiumfalciparumMutationsAssociatedDrugResistanceMicrohaplotypesProbesPrecisionSensitivityUganda

Similar Articles

Cited By